Interpretation and Management of the Dengue Duo Rapid Test (MMWR‑Based Recommendations)

Antibody Kinetics and Persistence

• IgM antibodies appear later in the acute phase of dengue infection and can persist for several months, limiting their usefulness for precise timing of infection. 1
• IgM antibodies also persist for months after infection, so a solitary positive IgM result cannot determine when the infection occurred. 2

Timing‑Based Interpretation of Rapid Test Results

Specimens Collected ≤ 7 Days After Symptom Onset

• If NS1 is negative but IgM and/or IgG are positive, a confirmatory nucleic‑acid amplification test (NAAT) or repeat serology should be performed because antibodies may not yet be fully developed. 3
• When all three markers (NS1, IgM, IgG) are negative, dengue infection cannot be excluded; NAAT should be performed if available. 3

Specimens Collected > 7 Days After Symptom Onset

• A positive IgM result (with or without IgG) strongly suggests a recent dengue infection; confirmatory plaque‑reduction neutralization testing (PRNT) is recommended when a definitive diagnosis is required. 3
• When both IgM and IgG are negative in samples taken 7 days to 12 weeks after onset, recent dengue infection is ruled out and alternative diagnoses should be considered. 1

Confirmatory Testing Recommendations

• Positive NS1 or IgM results that have not been confirmed by NAAT must be followed by PRNT against dengue, Zika, and other endemic flaviviruses to verify specificity. 3
• A PRNT titer ≥ 10 for dengue with a concurrent titer < 10 for Zika or other flaviviruses confirms a recent dengue infection. 1
• A PRNT titer ≥ 10 for both dengue and Zika indicates a recent flavivirus infection but does not allow definitive identification of the causative virus. 1

Interpretation of Negative Rapid Test Results

• In the early phase (< 7 days), a negative rapid test does not exclude dengue; NAAT testing should be considered to avoid missed diagnoses. 3
• In the late phase (> 7 days), if both IgM and IgG are negative, dengue infection is unlikely and clinicians should evaluate other possible causes of the patient’s illness. 1

Special Considerations for Pregnant Women

• For pregnant patients with suspected dengue, both NAAT and IgM antibody testing should be performed on serum, and NAAT should also be performed on urine to assess for possible Zika virus co‑infection. 4
• Specimens for Zika NAAT should be collected within ≤ 12 weeks of symptom onset to achieve optimal test sensitivity. 4

Incorporating Local Epidemiology

• Interpretation of rapid‑test results must take into account the local epidemiology of circulating dengue serotypes and co‑circulating flaviviruses, as these factors influence the likelihood of cross‑reactivity and the predictive value of the assay. 2

Evidence‑Based Recommendations for Dengue Diagnosis and Management in Filipino Primary Care

Diagnostic Criteria

• Suspect dengue in any patient who presents with fever plus at least one of the following: nausea, vomiting, rash, headache, retro‑orbital pain, myalgia, arthralgia, a positive tourniquet test, leukopenia, or any warning sign. CDC MMWR Recommendations and Reports define this clinical case definition. 5

Laboratory Testing Strategy

Specimens collected ≤ 7 days after symptom onset

• Perform nucleic acid amplification testing (NAAT) on serum as the primary diagnostic test for early dengue infection. CDC MMWR Recommendations and Reports endorse NAAT in this time window. 5
• NS1 antigen testing may be used as an alternative or adjunct to NAAT when NAAT is unavailable or as a rapid screening tool. This recommendation is also from CDC MMWR Recommendations and Reports. 5

Specimens collected > 7 days after symptom onset

• Use IgM antibody testing as the primary diagnostic modality for dengue when the sample is taken after the first week of illness. This approach is supported by CDC MMWR Recommendations and Reports. 5

Special Populations

• In pregnant women, dengue infection is associated with increased risk of maternal death, hemorrhage, pre‑eclampsia, eclampsia, and vertical transmission to the fetus. These risks are highlighted in the CDC MMWR Recommendations and Reports. 5

Differential Diagnosis

• When evaluating a patient with suspected dengue, clinicians should also consider and rule out other infections that can present with similar febrile illness, including chikungunya, Zika, malaria, rubella, measles, hepatitis A, parvovirus, adenovirus, enterovirus, leptospirosis, rickettsiosis, and group A streptococcal infections. This comprehensive list is provided by CDC MMWR Recommendations and Reports. 5